维普期刊资源整合服务平台（V6.5）

78篇 您的检索式：作者名="DHAINAUT JF"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation显示文摘	Dhainaut JF Yan SB	2004	J Thromb Haemost2004，2，11：	1
2	Transforming growth factor-beta:a mediator of cell regulation in acute respiratory distress syndrome显示文摘	DHAINAUT JF CHICHE J CHICHE JD	2003	Crit Care Med2003，31，4：	1
3	Bedside evaluation of right ventricular performance using a rapid computerized thermodilution method显示文摘	Dhainaut JF Brunet F Monsallier JF	1987	Crit Care Med1987，15，2：	1
4	Hepatic response to sep- sis: interaction between coagulation and inflammatory processes 显示文摘	Dhainaut JF Matin N Mignon A	2001	Crit Care Med2001，29，7：	1
5	Mechanisms of decreased left ventricular preload during continuous positive pressure ventilation in ARDS显示文摘	Devaux JY Monsallier JF	1986	Chest1986，90，1：	1
6	The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology,and results显示文摘	Dhainaut JF Laterre PF LaRosa SP	2003	Crit Care Med2003，31，9：	1
7	Protein C/activated protein C pathway: Overview of clinical trial results in severe sepsis 显示文摘	Dhainaut JF Yah SB Claessens YE	2004	Crit Care Med2004，，：	1
8	Adjunctive therapies in sepsis: an evidence -based review显示文摘	Cariou A Vinsonneau C Dhainaut JF	2004	Crit Care Med2004，32，11：	1
9	Soluble thrombomodulin,plasma-derived unactivated protein C and recombinant human activated protein C in sepsis显示文摘	Dhainaut JF Yan SB Cariou A	2002	Crit Care Med2002，30，5：	1
10	Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome:results from a randomized double-blind,placebo-controlled trial显示文摘	Fisher CJ Dhainaut JF Opal SM		0，，：	1
11	Soluble thrombomodulin,plasma-derived unactivated protein C,and recombinant human activated protein C in sepsis显示文摘	Dhainaut JF Yan SB Cariou A	2002	Crit Care Med2002，30，5：	1
12	Myocardial dysfunction in sep- sis显示文摘	Dhainaut JF Cariou A Laurent I	2011	Sepsis2011，4，2：	1
13	Influence of an antitumorrecrosis factor monoclonal antibody on cytokine levels in patients with sepsis显示文摘	Fisher CJ Opal SM Dhainaut JF	1993	Crit Care Med1993，21，5：	1
14	Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction:data from the PROWESS tria1显示文摘	LATERRE PF JANES JM et a1	2003	Intensive Care Med2003，29，：	1
15	Dynamic evolution of coagulopathy in the first day of severe sepsis:relationship with mortality and organ failure显示文摘	Dhainaut JF Shorr AF Macias WL	2005	Crit Care Med2005，33，2：	1
16	Soluble thrombomodulin, plasma- derived unactivated protein C, and recombinant human activated protein C in sepsis 显示文摘	Dhainaut JF Yan SB Cariou A	2002	Crit Care Med2002，30，5：	1
17	Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation 显示文摘	Dhainaut JF Yan SB Joyce DE	2004	J Thromb Haemost2004，2，：	1
18	Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation 显示文摘	Dhainaut JF Yan SB Joyce DE	2004	J Thromb Haemost2004，2，11：	1
19	Diagnosis and treatment of severe sepsis 显示文摘	Claessens YE Dhainaut JF	2007	Crit Care2007，11，5：	1
20	Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure 显示文摘	Dhainaut JF Shorr AF Macias WL	2005	Crit Care Med2005，33，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示